1. Role of Immune Cells and Immune-Based Therapies in Pancreatitis and Pancreatic Ductal Adenocarcinoma 
Lei Zheng, Jing Xue, Elizabeth M. Jaffee, Aida Habtezion 
Gastroenterology 
Volume 144, Issue 6, Pages (May 2013)
DOI: /j.gastro
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Immune cell involvement in PDA, AP, and CP. Recurrent and continued pancreatic injury can lead to CP, which can progress to PDA, although most PDA likely arises independent of pancreatitis. CTL, cytotoxic T lymphocyte; LPS, Lipopolysaccharide; NK, natural killer cells; PDGF, platelet derived growth factor; ROS, reactive oxygen species.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Immune cell infiltrates during pancreatic tumor progression. Infiltration by immune cells with immunosuppressive activities allows for an environment that fosters tumor growth and progression. Sequential acquisition of mutations in proto-oncogene K-RAS and the tumor suppressors INK4A, TP53, DPC4, BRCA2, and overexpression of cyclin D1 and mesothelin lead to pancreatic tumor progression. Teff, effector T cells.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

4. Gastroenterology 2013 144, 1230-1240DOI: (10. 1053/j. gastro. 2012. 12
Copyright © 2013 AGA Institute Terms and Conditions

5. Gastroenterology 2013 144, 1230-1240DOI: (10. 1053/j. gastro. 2012. 12
Copyright © 2013 AGA Institute Terms and Conditions

6. Gastroenterology 2013 144, 1230-1240DOI: (10. 1053/j. gastro. 2012. 12
Copyright © 2013 AGA Institute Terms and Conditions

7. Gastroenterology 2013 144, 1230-1240DOI: (10. 1053/j. gastro. 2012. 12
Copyright © 2013 AGA Institute Terms and Conditions